(Q37174057)

18 August 2017

In vitro and in vivo suppression of hepatocellular carcinoma growth by midkine-antisense oligonucleotide-loaded nanoparticles (English)

1 reference

18 August 2017

0 references

hepatocellular carcinoma

1 reference

Li-Cheng Dai

1

1 reference

18 August 2017

Xing Yao

2

1 reference

18 August 2017

Xiang Wang

3

1 reference

18 August 2017

Shu-Qiong Niu

4

1 reference

18 August 2017

Lin-Fu Zhou

5

1 reference

18 August 2017

Fang-Fang Fu

6

1 reference

18 August 2017

Shui-Xin Yang

7

1 reference

18 August 2017

Jin-Liang Ping

8

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

World Journal of Gastroenterology

18 August 2017

1 reference

18 August 2017

15

1 reference

18 August 2017

16

1 reference

18 August 2017

1966-1972

1 reference

Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675086

Inhibition of tumor growth and metastasis with antisense oligonucleotides (Cantide) targeting hTERT in an in situ human hepatocellular carcinoma model

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675086

Midkine antisense oligodeoxyribonucleotide inhibits renal damage induced by ischemic reperfusion

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675086

Global cancer statistics, 2002

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675086

Formation and intracellular trafficking of lipoplexes and polyplexes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675086

Antisense oligodeoxynucleotide targeted to Midkine, a heparin-binding growth factor, suppresses tumorigenicity of mouse rectal carcinoma cells.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675086

The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675086

Increased expression of midkine during the progression of human astrocytomas

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675086

A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675086

Differential expression of pleiotrophin and midkine in advanced neuroblastomas.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675086

Antisense oligonucleotides targeting midkine induced apoptosis and increased chemosensitivity in hepatocellular carcinoma cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675086

Combinational antitumor effect of siRNA against midkine and paclitaxel on growth of human prostate cancer xenografts

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675086

Estimates of cancer incidence in China for 2000 and projections for 2005.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675086

Expression of midkine and pleiotropin in ovarian tumors.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675086

Midkine is a mediator of retinoic acid induced neuronal differentiation of embryonal carcinoma cells

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675086

Identification of nucleolin as a binding protein for midkine (MK) and heparin-binding growth associated molecule (HB-GAM).

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675086

Increased midkine gene expression in human gastrointestinal cancers.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675086

Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675086

Immunohistochemical analysis of midkine expression in human prostate carcinoma

3 September 2018

1 reference

12 December 2020

Midkine and pleiotrophin expression in normal and malignant breast tissue

1 reference

12 December 2020

The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers

1 reference

12 December 2020

Antisense oligonucleotides targeting midkine inhibit tumor growth in an in situ human hepatocellular carcinoma model

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.15.1966

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19399928

1 reference